# A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD

> **NCT00457951** · PHASE2 · TERMINATED · sponsor: **Jazz Pharmaceuticals** · enrollment: 158 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Open-Label
- **DRUG:** Placebo Comparator: Placebo-Control Arm 0.9% Sodium Chloride
- **DRUG:** ODSH

## Key facts

- **NCT ID:** NCT00457951
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2009-08
- **Final completion:** 2009-10
- **Target enrollment:** 158 (ACTUAL)
- **Why stopped:** Interim analysis: safety without efficacy ODSH in patients with acute COPD.
- **Last updated:** 2021-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00457951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00457951, "A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00457951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*